1. Home
  2. WFF vs PASG Comparison

WFF vs PASG Comparison

Compare WFF & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WF Holding Limited Ordinary Shares

WFF

WF Holding Limited Ordinary Shares

HOLD

Current Price

$0.11

Market Cap

16.9M

ML Signal

HOLD

Logo Passage Bio Inc.

PASG

Passage Bio Inc.

N/A

Current Price

$3.50

Market Cap

14.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WFF
PASG
Founded
1984
2017
Country
Malaysia
United States
Employees
N/A
27
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.9M
14.6M
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
WFF
PASG
Price
$0.11
$3.50
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $15.50
AVG Volume (30 Days)
★ 19.3M
19.9K
Earning Date
11-24-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.13
$3.29
52 Week High
$50.60
$20.00

Technical Indicators

Market Signals
Indicator
WFF
PASG
Relative Strength Index (RSI) 43.53 35.96
Support Level N/A $3.29
Resistance Level $2.04 $5.04
Average True Range (ATR) 5.63 0.39
MACD -0.42 -0.07
Stochastic Oscillator 0.01 7.95

Price Performance

Historical Comparison
WFF
PASG

About WFF WF Holding Limited Ordinary Shares

WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings, and other custom-made FRP products. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance. Geographically, the company generates the majority of its revenue from Australia.

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Share on Social Networks: